Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiri Vencovsky

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Annals of the Rheumatic Diseases|February 19, 2017
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritisGerd R Burmester, Iain B McInnes, Joel Kremer, et al.
Arthritis Research & Therapy|January 10, 2012
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysisKatja Lakota, Gerhard G Thallinger, Snezna Sodin-Semrl, et al.
Annals of the Rheumatic Diseases|February 19, 2016
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationCarina Götestam Skorpen, Maria Hoeltzenbein, Angela Tincani, et al.
Annals of the Rheumatic Diseases|February 26, 2015
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseasesMegan K Herbert, Judith Stammen-Vogelzangs, Marcel M Verbeek, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profilesDidem Saygin, Hanna Kim, Christian Douglas, et al.
Seminars in Arthritis and Rheumatism|August 23, 2024
Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international networkFabricio Espinosa-Ortega, Karin Lodin, Maryam Dastmalchi, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across EuropeKarim Raza, Rebecca Stack, Kanta Kumar, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profilesHanna Kim, Didem Saygin, Christian Douglas, et al.
The Journal of Clinical Investigation|November 10, 2015
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathiesInka Albrecht, Cecilia Wick, Åsa Hallgren, et al.
Arthritis Research & Therapy|February 18, 2016
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseasesTamarah D de Jong, Saskia Vosslamber, Elise Mantel, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Annals of the Rheumatic Diseases|February 19, 2017
A randomised phase IIb study of mavrilimumab, a novel GM-CSF receptor alpha monoclonal antibody, in the treatment of rheumatoid arthritisGerd R Burmester, Iain B McInnes, Joel Kremer, et al.
Arthritis Research & Therapy|January 10, 2012
International cohort study of 73 anti-Ku-positive patients: association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysisKatja Lakota, Gerhard G Thallinger, Snezna Sodin-Semrl, et al.
Annals of the Rheumatic Diseases|February 19, 2016
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactationCarina Götestam Skorpen, Maria Hoeltzenbein, Angela Tincani, et al.
Annals of the Rheumatic Diseases|February 26, 2015
Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseasesMegan K Herbert, Judith Stammen-Vogelzangs, Marcel M Verbeek, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR Myositis Response Criteria in adult dermatomyositis/polymyositis therapeutic trials and consensus profilesDidem Saygin, Hanna Kim, Christian Douglas, et al.
Seminars in Arthritis and Rheumatism|August 23, 2024
Autoantibodies and damage in patients with idiopathic inflammatory myopathies: A longitudinal multicenter study from the MYONET international networkFabricio Espinosa-Ortega, Karin Lodin, Maryam Dastmalchi, et al.
Annals of the Rheumatic Diseases|August 9, 2011
Delays in assessment of patients with rheumatoid arthritis: variations across EuropeKarim Raza, Rebecca Stack, Kanta Kumar, et al.
Rheumatology (Oxford, England)|March 17, 2023
Performance of the 2016 ACR-EULAR myositis response criteria in juvenile dermatomyositis therapeutic trials and consensus profilesHanna Kim, Didem Saygin, Christian Douglas, et al.
The Journal of Clinical Investigation|November 10, 2015
Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathiesInka Albrecht, Cecilia Wick, Åsa Hallgren, et al.
Arthritis Research & Therapy|February 18, 2016
Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseasesTamarah D de Jong, Saskia Vosslamber, Elise Mantel, et al.
Pageof 7